Humanized Monoclonal Antibody Fragment [EPC]

1321 reported adverse events

Drugs of this class: IDARUCIZUMAB

These side effects are most commonly reported by patients taking drugs of the Humanized Monoclonal Antibody Fragment [EPC] class:

# Side effect Count
0 DEATH 159
1 HAEMORRHAGE 101
2 GASTROINTESTINAL HAEMORRHAGE 77
3 CEREBRAL HAEMORRHAGE 75
4 HAEMORRHAGE INTRACRANIAL 66
5 DRUG INEFFECTIVE 59
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 58
7 ACUTE KIDNEY INJURY 43
8 ISCHAEMIC STROKE 42
9 SEPSIS 42
See all common reactions for Humanized Monoclonal Antibody Fragment [EPC]

Drugs of the Humanized Monoclonal Antibody Fragment [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIMB GIRTH INCREASED 1 0.1250
1 COAGULATION FACTOR INCREASED 5 0.0926
2 THROMBIN TIME ABNORMAL 3 0.0714
3 DECOMPRESSIVE CRANIECTOMY 1 0.0667
4 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0428
5 PROCEDURAL SHOCK 1 0.0385
6 BASILAR ARTERY ANEURYSM 1 0.0370
7 BASILAR ARTERY OCCLUSION 5 0.0362
8 BASAL GANGLIA HAEMATOMA 1 0.0323
9 SPLEEN SCAN ABNORMAL 1 0.0323
See all enriched reactions for Humanized Monoclonal Antibody Fragment [EPC]